LeMaitre Vascular EBITDA 2010-2025 | LMAT

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

LeMaitre Vascular ebitda from 2010 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

LeMaitre Vascular ebitda from 2010 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.

Related Stocks
Company Name	Market Cap
Abbott Laboratories (ABT)	$229.2B
Boston Scientific (BSX)	$152.7B
Stryker (SYK)	$149.2B
EssilorLuxottica (ESLOY)	$131.9B
Medtronic (MDT)	$115.1B
Lonza Group Ag (LZAGY)	$50.1B
Haleon (HLN)	$43.5B
ResMed (RMD)	$37.3B
GE HealthCare Technologies (GEHC)	$34.5B
Agilent Technologies (A)	$32.2B
Terumo (TRUMY)	$24.4B
Koninklijke Philips (PHG)	$23.5B
Insulet (PODD)	$20.3B
Zimmer Biomet Holdings (ZBH)	$18.6B
Baxter (BAX)	$14.6B
Smith & Nephew SNATS (SNN)	$13B
Sunny Optical Technology (SNPTF)	$10.4B
Demant (WILYY)	$8.6B
Bio-Rad Laboratories (BIO)	$6.7B
Lantheus Holdings (LNTH)	$5.1B
Perrigo (PRGO)	$3.7B
Prestige Consumer Healthcare (PBH)	$3.7B
Haemonetics (HAE)	$3.6B
Shandong Weigao Medical Polymer (SHWGF)	$3.5B
Envista Holdings (NVST)	$3.3B
ICU Medical (ICUI)	$3.1B
QuidelOrtho (QDEL)	$1.9B
AtriCure (ATRC)	$1.5B
Acuren (TIC)	$1.4B
Phibro Animal Health (PAHC)	$1.2B